# Argonaut Therapeutics Limited

## Details

- **Company number:** [09993166](https://find-and-update.company-information.service.gov.uk/company/09993166)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 8 Feb 2016
- **Registered office:** MAGDALEN CENTRE ROBERT ROBINSON AVENUE, OXFORD SCIENCE PARK, OXFORD, OX4 4GA
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology
- **Corporate group:** [Ingenox Therapeutics Limited](/group/30346) (2 companies)




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Prof Nicholas Barrie La Thangue | ownership-of-shares-25-to-50-percent | 6 Apr 2016 | 27 Sep 2018 |
| Oxford Sciences Innovation Plc | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 22 Dec 2022 |
| Ingenox Therapeutics Limited | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 22 Dec 2022 |  |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | - | £1,230 | 0 |
| 31 Dec 2024 | - | £98,540 | 0 |
| 28 Feb 2018 | £336,667 | £381,868 | 4 |
| 28 Feb 2017 | £117,528 | £164,301 | 4 |



## Owned by

Argonaut Therapeutics Limited → [Ingenox Therapeutics Limited](/company/14127227)





## Companies at the same address

- [Celleron Therapeutics Limited](/company/05162047) (05162047)
- [Ingenox Therapeutics Limited](/company/14127227) (14127227)
- [Prophase Development Limited](/company/05167257) (05167257)